Trial Profile
Prospective, observational, multicentre study investigating maintenance of viral suppression and improvement of endothelial function in HIV infected patients on Maraviroc (MVC) based combination antiretroviral therapy (cART)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Dec 2015
Price :
$35
*
At a glance
- Drugs Maraviroc (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 26 Dec 2015 New trial record